Feed PVLA
PV

Palvella Therapeutics, Inc.

PVLA · NASDAQ

$151.22 -0.98% (-$1.50)
1M -1.50%
Market Cap $2.17B
P/E Ratio -
Div. Yield -
ROE 47.84%
Piotroski F-Score Weak
3/9
Valuation
0 /100
Expensive
P/B 10.00x
P/E N/A
P/FFO N/A
Growth
-
N/A
EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A
Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor
ROIC 23.89%
Asset turnover 0.00x
ROE 47.84%
Debt
69 /100
Low
Debt/Equity 0.00x
Int. coverage -7.92x
Current ratio 21.18x
Stability
19 /100
Unstable
Beta -0.17x
Profitable years 0
EPS volatility 154.66%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o PVLA
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Wesley H. Kaupinen

Employees

29

Headquarters

Wayne

Prihajajoči dogodki

10 NOV.

Earnings

Upcoming earnings report

55d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.